5-Aminosalicylic acid-13C6
Modify Date: 2024-04-05 14:13:18
5-Aminosalicylic acid-13C6 structure
|
Common Name | 5-Aminosalicylic acid-13C6 | ||
|---|---|---|---|---|
| CAS Number | 1189709-96-3 | Molecular Weight | 159.09100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C7H7NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-Aminosalicylic acid-13C65-Aminosalicylic acid-13C6 is the 13C labeled 5-Aminosalicylic Acid[1]. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB[2][3][4]. |
| Name | 5-amino-2-hydroxybenzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 5-Aminosalicylic acid-13C6 is the 13C labeled 5-Aminosalicylic Acid[1]. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB[2][3][4]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C7H7NO3 |
|---|---|
| Molecular Weight | 159.09100 |
| Exact Mass | 159.06300 |
| PSA | 83.55000 |
| LogP | 1.25380 |
| Mesalazine-13C6 |